Sierra Ocean LLC Makes New $26,000 Investment in Haleon plc (NYSE:HLN)

Sierra Ocean LLC purchased a new position in shares of Haleon plc (NYSE:HLN) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,775 shares of the company’s stock, valued at approximately $26,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Lake Street Advisors Group LLC increased its stake in shares of Haleon by 5.4% during the third quarter. Lake Street Advisors Group LLC now owns 22,395 shares of the company’s stock worth $237,000 after buying an additional 1,143 shares during the period. Synovus Financial Corp increased its stake in shares of Haleon by 0.8% during the third quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock worth $1,575,000 after buying an additional 1,216 shares during the period. Greenleaf Trust increased its stake in shares of Haleon by 8.4% during the fourth quarter. Greenleaf Trust now owns 17,225 shares of the company’s stock worth $164,000 after buying an additional 1,333 shares during the period. Baron Wealth Management LLC increased its stake in shares of Haleon by 4.3% during the fourth quarter. Baron Wealth Management LLC now owns 33,632 shares of the company’s stock worth $321,000 after buying an additional 1,381 shares during the period. Finally, Peapack Gladstone Financial Corp increased its stake in shares of Haleon by 3.2% during the third quarter. Peapack Gladstone Financial Corp now owns 44,844 shares of the company’s stock worth $474,000 after buying an additional 1,390 shares during the period. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Haleon Stock Performance

Shares of HLN opened at $9.98 on Wednesday. The stock has a 50 day moving average price of $9.55 and a 200 day moving average price of $9.81. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $45.15 billion, a price-to-earnings ratio of 29.34, a price-to-earnings-growth ratio of 2.70 and a beta of 0.28. Haleon plc has a 52-week low of $7.89 and a 52-week high of $10.80.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Sanford C. Bernstein lowered shares of Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $10.95.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.